More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19.

Yang, Shengju; Meng, Guoliang

Yang, Shengju; Meng, Guoliang.

Yang S; Nantong University, Nantong, China; Affiliated Hospital of Nantong University, Nantong, China.
Meng G; Nantong University, Nantong, China. Electronic address: mengguoliang@ntu.edu.cn.

J Mol Cell Cardiol ; 141: 110-111, 2020 04.

Article in English | MEDLINE | ID: covidwho-34773

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Antihypertensive Agents/therapeutic use; Betacoronavirus/physiology; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors/metabolism; Animals; COVID-19; Coronavirus Infections/virology; Disease Models, Animal; Humans; Pandemics; Peptidyl-Dipeptidase A/metabolism; Pneumonia, Viral/virology; Renin-Angiotensin System/drug effects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Betacoronavirus / Antihypertensive Agents Limits: Animals / Humans Language: English Journal: J Mol Cell Cardiol Year: 2020 Document Type: Article Affiliation country: J.yjmcc.2020.04.003

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google